Abstract
Quantitative imaging with the positron emitter 86Y is the method of choice to determine the uptake and dosimetry of 90Y-labelled radiopharmaceuticals. To examine the quantitative accuracy of positron emission tomography findings with 86Y, this non-pure positron emitter was evaluated in a cylindrical phantom with rods of Teflon, water and air and measured with three different scanners: ECAT EXACT (2D/3D), ECAT HR+ (2D/3D) and PC4096+ (2D). After standard reconstruction, 86Y radioactivity measured with the ECAT EXACT and related to the true radioactivity varied between 0.84 and 0.99 in 2D and between 0.93 and 1.20 in 3D from the first to the last acquisition (eight half-life times later). The water and Teflon rods exhibited considerable amounts of reconstructed radioactivity—21% in 2D and 67% in 3D for water and 65% and 147%, respectively, for Teflon—compared with the actual 86Y radioactivity of the phantom. For the ECAT HR+ similar results were obtained in 3D, but there were even greater overestimations in 2D. Measurements with the PC4096+ showed rather small errors, with 10% for water and 20% for Teflon. To correct for the background of γ-coincidences, sinograms were analysed and an experimental percentage of the background was subtracted from the sinograms. In order to minimise the errors in reconstructed radioactivity, the subtraction value had to be different for the individual scanners and modes. Our results demonstrate that 90Y/86Y-based dosimetry for bone and red marrow must be regarded with caution if it is derived from regions of interest over the bone, the density of which is similar to that of Teflon. To obtain more reliable estimates, an appropriate background correction must be applied and tailored individually with respect to the scanner and acquisition mode.
This is a preview of subscription content, log in via an institution to check access.
References
Herzog H, Rösch F, Stöcklin G, Lueders C, Qaim SM, Feinendegen LE. Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics. J Nucl Med 1993; 34:2222–2226.
Rösch F, Herzog H, Plag C, Neumaier B, Braun U, Müller-Gärtner HW, Stöcklin G. Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography. Eur J Nucl Med 1996; 23:958–966.
Rösch F, Herzog H, Stolz B, Brockmann J,Köhle M, Mühlensiepen H, Marbach P, Müller-Gärtner HW. Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-dPhe1-Tyr3-octreotide ([86Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labeled analogue. Eur J Nucl Med 1999; 26:358–366.
Pentlow KS, Finn RD, Larson SM, Erdi YE, Beattie BJ, Humm JL. Quantitative imaging of yttrium-86 with PET. The occurrence and correction of anomalous apparent activity in high density regions. Clin Positron Imaging 2000; 3:85–90.
Lubberink M, Schneider H, Bergstrom M, Lundqvist H. Quantitative imaging and correction for cascade gamma radiation of76Br with 2D and 3D PET. Phys Med Biol 2002; 47:3519–3534.
Yamamoto M, Ficke DC, Ter-Pogossian M. Performance study of PETT VI, a positron computed tomograph with 288 cesium fluoride detectors. IEEE Trans Nucl Sci 1982; 29:529–533.
Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992; 16:804–813.
Brix G, Zaers J, Adam L, Bellemann M, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med 1997; 38:1614–1623.
Rota Kops E, Herzog H, Schmid A, Holte S, Feinendegen LE. Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr 1990; 14:437–445.
Bergström M, Eriksson L, Bohm C, Blomqvist G, Litton J. Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections. J Comput Assist Tomogr 1983; 7:42–50.
Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci 2000; 47:1587–1594.
Förster GJ, Engelbach MJ, Brockmann JJ, Reber HJ, Buchholz HG, Macke HR, Rösch F, Herzog H, Bartenstein P. Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of86Y-DOTATOC and 111In-DTPA-octreotide. Eur J Nucl Med 2001; 28:1743–1750.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buchholz, H.G., Herzog, H., Förster, G.J. et al. PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction. Eur J Nucl Med Mol Imaging 30, 716–720 (2003). https://doi.org/10.1007/s00259-002-1112-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-002-1112-y